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1. Introduction  
Ernst Haeckel first described the term “stem” as a concept for the evolution or organisms. 
For representation purpose he described the ancestor organism as a “stem” from which all 
the other organisms evolved. Arthur Pappenheim later adopted this concept in the context 
of cells, and he elegantly placed the “stem cell” in the centre in cartoon from which all the 
blood cells arise describing hematopoiesis (Ramalho-Santos and Willenbring, 2007). 
The concept was carried forward and the term “cancer stem cell” was first coined in 1980 
(Carney et al., 1982) where the authors described the stem cell origin of lung cancer cells. The 
difficulty in isolation and the absence of specific markers of cancer stem cell stalled the 
research in this area. However a decade later Bonnet and Dick successfully isolated CSC in 
AML which then incited the development in the field of cancer stem cells (Bonnet and Dick, 
1997). Their discovery was later supported by many groups, which also resulted in isolation 
of CSC from a variety of malignancies including solid tumors. 
Now a large body of evidence suggests that cancer comprises of different population of cells 
with various tumorogenic potentials. The tumor cells follow a hierarchy, where the subset 
capable of self-renewal, generate the tumor heterogeneity and are called cancer stem cells 
(CSC). Very low number of these cancer stem cells generates tumors in 
immunocompromised mice whereas large number of non-CSCs fails to generate tumors. 
CSCs have been characterized based on their ability to form colonies in soft agar and their 
ability to form spheres in serum free media. The generation of tumors in 
immunocompromised mice however remains the gold standard. Another characteristic of 
CSC  is their ability to resist the action of common chemotherapeutic drugs which is 
attributed to higher expression of ABC transporters and their slow cycling nature. Further it 
has also been documented that these CSCs have activated signaling pathways as in the case 
of normal stem cells. Hence CSCs are distinct from other non-CSC in many respects. 
Cancer stem cells have been isolated based on membrane markers. One of the characteristics 
is their ability to efflux the Hoechst dye. However this ability to efflux the dye is also 
attributed to membrane ABC transporter ABCG2. ABCG5 has been used as a cancer stem 
cell marker as it pumps out the drug doxorubicin. ALDH1 has the ability to convert retinol 
to retinoic acid, which has diverse role in cell physiology, and this activity is used as a 
marker for CSC. CD 44, CD 133, EpCAM and CD 90 are also abundantly expressed in CSCs 
and are used to isolate or enrich CSC (Visvader and Lindeman, 2008). A number of groups 
have isolated CSC based on these markers however a robust marker for CSC still remains to 
be identified.  
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1.1 Origin of CSC 
A number of theories have been proposed for the generation of these CSCs. (1)CSC can 
originate from genetic/ epigenetic alteration of normal stem cells or from the progenitor 
cells. (2) They can be derived from somatic tumor cells by de differentiation or 
reprogramming into a stem- like cell (Visvader and Lindeman, 2008). (3) And recently it has 
been suggested that CSC can be generated from non-CSC through production secretary 
molecules (Iliopoulos et al., 2011). 
2. Breast cancer stem cells 
The existence of cancer stem cells was first demonstrated in solid tumors by Al Hajj et al., 
where CSCs were identified from human breast cancer tissue using CD44+ / CD24- Lin- as 
cellular markers (Al-Hajj et al., 2003). They isolated the cells from primary breast cancer or 
metastatic pleural effusions and injected them directly in to mice or after cellular sorting 
with the above mentioned markers. They found that CD44+, CD24- were able to form tumors 
while CD44- , CD24- were unable to form tumors in immunocompromised mice. Further 
they performed repopulation assays where they found that the tumorigenic population 
(CD44+ / CD24- Lin-) was able to give rise to phenotypic heterogeneity of the initial tumor. 
This suggested that the breast cancer stem cells undergo self-renewal and differentiation as 
in the case of normal stem cells. After this report a large number of studies identified CSC 
from various other malignancies (Curley et al., 2009; Fang et al., 2005; Kondo et al., 2004; Liu 
et al., 2007; Prince et al., 2007; Singh et al., 2004).  
The normal stem cells reside in a distinct environment called the “stem cell niche”. This 
stem cell niche consists of complex composition of ECM, soluble factors, stromal cells, 
immune cells which are responsible for maintaining the self renewal ability of stem cells. 
Similarly the CSCs also depend on similar environment, which may be altered in many 
ways. Moreover in some of the tumors, the tumor niche has been shown to have a protective 
role from genotoxic insults (Garcia-Barros et al., 2003). Although much research has been 
done on understanding the cancer stem cells, very few studies have been carried out on 
understanding the microenvironment of breast cancer stem cells and their targeting. We 
believe that understanding the breast cancer microenvironment will offer easily tractable 
solutions to cancer therapy. 
2.1 Role of microenviroment in mammary gland development 
The breast tissue is composed of multiple cell types for proper functioning of tissue and the 
primary function of which is production of milk. During lactation milk is produced by the 
luminal epithelial cells and secreted in the hollow cavity. The luminal epithelial cells are 
surrounded by myoepithelial cells, which synthesize the basement membrane. Together the 
luminal epithelia and the myoepithelia form the milk duct. Different cell types whose 
function is to maintain the homeostasis surround milk duct. These cells include fibroblasts, 
leucocytes and endothelial cells. 
The environment of epithelial cells plays a critical role in shaping their function. For eg. 
When the epithelial cells from breast tissue were placed on plastic, they were unable to 
produce milk and exhibited different phenotype as compared to the cells when plated in 3 
dimentional reconstituted basement membrane (Matrigel) which led to proper function of 
epithelial cells (Howlett and Bissell, 1993; Petersen et al., 1992). Hence proper cellular 
interaction and spatial localization of cells with the right constituents are required for 
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correct functioning of epithelial tissue. This was explained by the fact that invivo normal 
mammary gland are in contact with myoepithelial cells and not the basement membrane.  
Further luminal epithelial cells display apical–basal polarity as demonstrated by MUC 1, 
ESA and occludin expression on the apical membrane and ß4 integrin on the basolateral 
membrane. However such a polarity is observed when luminal cells are grown in matrigel 
but not in collagen(Gudjonsson et al., 2002). The polarity is restored when the myoepithelial 
cells are co- cultured with luminal epithelial cells even in collagen, which is mediated by 
laminin 1 secreted by myoepithelial cells. These studies demonstrate the role of 3D 
environment and is important for optimal function of epithelial cells.  
2.1.1 Microenvironment of breast cancer cells 
A large number of reports demonstrate that breast tumor progression is facilitated by 
stromal cells and that their presence is critical for survival of cancer cells. However it is 
also important to note that the normal mammary gland microenvironment has inhibitory 
effect on breast cancer progression (DeCosse et al., 1973). This indicates that cancer cells 
can maintain their properties only in an abnormal microenvironment. One of the recent 
reports underlies the role of mesenchymal stem cells in amplifying the metastatic 
potential of weakly metastatic cells. Karnoub A et al mixed a weakly metastatic cell line 
MDA MB 231 with bone marrow derived human MSC and found that the metastatic 
potential of the cell line is dramatically increased (Karnoub et al., 2007). To further 
understand the mechanism of this increase in metastatic potential they used a cytokine 
array to identify soluble factors. They found CCL5 release, which was induced by 
physical interaction between breast cancer cells and the MSC, and that it renders the 
breast cancer cells more metastatic.  
Another seminal report by Kaplan et al demonstrate that bone marrow- derived 
hematopoietic progenitors may localize to future sites of metastasis and “prepare” the sites 
for the arrival and growth of disseminated cancer cells (Kaplan et al., 2005). This has been 
proposed a new concept in metastasis, which is called the “premetastatic niche”. The precise 
mechanism and the factors responsible for such localization of bone marrow derived 
hematopoietic progenitors is unclear however it appears to be derived from the serum 
(Kaplan et al., 2005). 
One of the extensive study in understanding the breast cancer microenvironment, Allinen et 
al. performed genome wide gene expression analysis of stromal cells (Endothelial cells, 
infiltrating leukocytes, fibroblasts, and myofibroblasts) and breast epithelial cells (luminal 
epithelial and myoepithelial cells) from normal, insitu carcinoma and invasive carcinoma. 
The authors found that alterations in gene expression takes place in all cell types however 
clonally selected genetic alterations are confined to tumor epithelial cells. Further there were 
consistent and significant alterations in myoepithelial cells from DCIS as compared to 
normal myoepithelial cells and many of these changes were in secreted proteins and cell 
surface receptors (Allinen et al., 2004). This further underlines the importance of soluble 
factors in breast cancer progression. 
Although a large amount of literature is present on microenvironment of breast cancer cells, 
there are few studies on cancer stem cell microenviroenment. This is ascribed to the age of 
this new field however research in this direction will significantly impact the therapy of 
breast cancer. 
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Fig. 1. Microenvironment of normal breast epithelium and breast cancer cells. 
2.1.2 Influence of microenvironment on development of breast cancer stem cells 
A limited number of factors have been studied to understand the interaction of 
microenvironment generated by tumors and its effect on development and maintenance of 
cancer stem cells. One of the widely studied environment which the solid tumors reside in, 
is hypoxia. 
2.1.2.1 Hypoxia 
It has been suggested that hypoxia contributes to the generation aggressive cancer by 
selecting tumor cells and results into growth of cells that can survive compromised levels of 
oxygen and nutrients (Graeber et al., 1996). Further the growth of tumor results in hypoxic 
microenvironment, which is followed by periods of reoxygenation. Hence to mimic the 
invivo environment and to assess the fate of cells undergoing periods of hypoxia-
reoxygenation Louie E etal., exposed breast cancer cells (MDA-MB-231 and BCM2) to cycles 
of hypoxia and nutrient deprivation. They discovered that after the first cycle of hypoxia a 
small fraction of cells survived and that repetitive exposure of the same cells to hypoxia and 
reoxygenation led to increased viability under hypoxia and to proliferate either as 
monolayer or tumor spheres. They also found increase in the number of cells expressing 
CD44+/CD24-/ESA+ cell surface markers, and hence the cancer stem cell content. Therefore 
repetitive cycling of hypoxia and re-oxygenation can increase the stem cell content of 
metastatic breast cancer cell lines indicating that microenvironment plays an important role 
in selectively increasing CSC (Louie et al., 2010). 
2.1.2.2 Stromal cells 
Carcinoma associated fibroblasts (CAF) 
For a long time scientist have primararily focused on epithelial component of breast cancer, 
however recently, the critical importance of tumor stroma has been realized. Literature 
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documents important interaction between mammary epithelia and the adjacent tumor stroma. 
One of the reports demonstrates that CAF increases the number of CD44+CD24- cells in 
mammospheres, whereas normal fibroblasts (NFs) down-regulated it in mammospheres. They 
also demonstrate increase in the ability to form epithelial tumors in immunocompromised 
mice in presence of CAF. This indicates that CAFs can increase the cancer stem cell population 
in breast cancer (Huang et al., 2010). Furthermore since, CXCR4 expression on carcinoma cells 
is known to correlate with a poor prognosis for several types of carcinomas (Balkwill, 2004), 
the authors assessed CXCR4 gene expression in mamosphere co cultured with CAF. They 
found increase expression of CXCR4 and it was speculated that increase in cancer stem cell 
population could be because of CXCR4 signaling (Huang et al., 2010). 
The normal fibroblasts on the contarary have a inhibitory effect on the tumor growth. For 
e.g Coculture studies using different mesenchymal cells and MCF10A and preneoplastic 
MCF10AT1-EIII8 mammary epithelial cells showed that fibroblasts derived from normal 
reduction mammoplasty inhibit or retard the morphological conversion and growth of 
MCF10A and EIII8 cells, whereas tumor derived fibroblasts evoke ductal-alveolar 
morphogenesis of both cell types (Shekhar et al., 2001). Further caveolin-1 deficient (Cav1-/-) 
mammary stromal fibroblasts were shown to mimic the effects of human breast cancer 
associated fibroblasts as they show similar profile of RB/ E2F-regulated genes that are up-
regulated and confer a poor prognosis with enhanced epithelial-mesenchymal transition 
(EMT) (Sotgia et al., 2009). 
Interestingly, genome-wide expression profiling of human breast cancer-associated 
fibroblasts and Cav-1 (-/-) mammary stromal fibroblasts indicates that they both show the 
upregulation of a number of ES-cell related genes and factors (Oct4, Nanog, Sox2 and Myc-
target genes), indicating that they may behave like “cancer stem cells”. Thus, the tumor 
stromal microenvironment may directly contribute to maintaining the “cancer stem cell” 
phenotype, leading to drug-resistance and treatment failure (Sotgia et al., 2009). 
Fibroblast synthesize growth and survival factors which are critical for the tumor. In breast 
cancer, stromal fibroblasts evolve with the tumor epithelial cells and assist the growth of 
tumor cells. Inspite of much known about role of stromal cells the mechanistic basis of such 
a requirement of fibroblast remains elusive. PTEN is a tumor suppressor and is a critical 
regulator of PI3K signaling whose activation is associated with activation of tumor stroma 
(Cully et al., 2006). To understand the role of  fibroblast in tumor formation Trimboli et al 
deleted PTEN from fibroblast in MMTV- ERBB2 mice model. They found that deletion of 
PTEN from fibroblast results in increase incidence and tumor load in the mice model. 
Extensive remodeling of ECM and increased recruitment of innate immune cells were some 
of the salient findings. Gene expression analysis revealed that PTEN deleted stromal 
fibroblasts consists of activation of Ets2 transcription factor. Further double transgenic mice 
having inactivation of Ets2 in mammary stroma reversed the increased malignancy caused 
by PTEN deficiency. These observations show the importance of the PTEN-Ets2 axis in 
stromal fibroblasts in the MMTV-ErbB2 model in suppressing breast cancer growth and 
indicate the stromal pathway contributes to the complexity of human breast cancer stroma 
(Trimboli et al., 2009). 
Mesenchymal stem cells 
Mesenchymal stem cells localize to the breast carcinoma and integrate into tumor associated 
stroma. A seminal report by Ling X et al.,  demonstrate that MSC overexpressing IFN-beta 
inhibit breast cancer growth and metastasis (Ling et al., 2010). They demonstrate that MSC 
www.intechopen.com
 
Breast Cancer – Focusing Tumor Microenvironment, Stem Cells and Metastasis 
 
242 
are recruited to tumors and that IFN-beta inhibits tumor growth. (Ling X 2010). Such a 
reduction in tumor could also be attributable to decrease CSC content. Karnoub A et al., 
have shown increase in the metastatic potential of the breast cancer cells when they were 
mixed with bone marrow derived human MSC. Using a cytokine array they identified CCL5 
is induced by physical interaction between breast cancer cells and the MSC, and that it 
renders the breast cancer cells more metastatic. These results indicate the importance of 
mesenchymal stem cells in rendering the cells more metastatic (Karnoub et al., 2007). 
2.1.2.3 Stromal factors  
IL-6 
IT has been documented that CSCs arise from mutant versions of normal stem cells. 
Alternatively, CSCs can also represent a stage in the path of transformation. CSCs are 
precursors of differentiated cancer cells (NSCCs), however CSCs can also be derived from 
NSCCs or can arise independently. The proportion of CSCs remains constant over multiple 
generations, but the basis of this phenomenon is unknown. Hence Iliopoulos D et al.,  assessed 
these issues using an inducible model of oncogenesis that MCF-10A cells which harbor a 
ligand-binding domain of estrogen receptor (ER-Src), a derivative of the Src kinase 
oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor. 
Treatment of these cells with tamoxifen (TAM) rapidly induces Src, results in transformation 
within 24-26 h. This property of the model helps in understanding the transition between 
normal and transformed cells. The authors then discovered that induction of CSC from non-
CSC through activation of v-src. They also document that CSC formation depends on 
transformation however it is not required for transformation. Moreover because of the fact that 
breast CSCs have an enhanced inflammatory feedback loop compared with NSCCs, they 
treated the cells with IL6 which resulted in generation of CSC fron non-CSC (Iliopoulos et al., 
2011). This indicates the critical role of microenvironment as the CSC itself secrete IL6 which 
can maintain the stemness of a cancer cell population. Further the fact that macrophages and 
dendritic cells are potent IL-6 producers, which can be activated by molecular “danger” 
signals by cancer cells it is important to control the IL6 signaling to regenerate the CSC . 
TGF beta 
One of the elegant studies by Mani et al demonstrates the role of TGF beta in cancer stem 
cell through induction of EMT. The authors treated the immortalized HMEC cells with TGF 
beta which resulted in fibroblast like, mesenchymal like phenotype with concomitant 
downregulation of ephtielial markers like E-cadherin and upregulation of mesenchymal 
markers like vimentin, fibronectin and N-cadherin. Similar results were obtained through 
ectopic expression of TWIST or SNAI1. They further assessed the CD44 and CD24 
population of these cells and found that CD44+ and CD24 low cells were increased which 
TGF beta treatment/ TWIST, SNAI1 expression. The rise in CD44+ and CD24 low 
population was accompanied by approximately 30-40 fold enrichment in mamosphere 
forming capability (Mani et al., 2008). This was a clear demonstration of TGF beta induction 
of cancer stem cell population. 
Yin X et al.,  showed that the activating transcription factor 3 (ATF3) is induced by TGF beta 
in breast cancer and is important for increasing the migration potential of the breast cancer 
cells. Further ATF3 can be induced by a number of stromal factors like TGF beta, IFN alpha, 
TNF alpha and hypoxia. And the fact that ectopic expression of ATF3 increases the cancer 
stem cell content of breast cancer cells (CD 24low/ CD 44high), it was hypothesized that tumor 
microenvironment has a significant effect in the development of cancer (Yin et al., 2010). 
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2.1.2.4 Embryonic microenvironment 
Four decades back it was documented that embryonic microenvironment can reprogram the 
cancer cells to a benign phenotype; however, the mechanisms underlying this phenomenon 
remains unclear (Hendrix et al., 2007). The human embryonic stem cells (hESC) and cancer 
cells have various common features however hESC do not form tumors owing to the ability 
to differentiate in response to signals from the microenvironment. Normally the stem cell 
microenvironment or the stem cell niche controls the fate of the stem cells and that it 
provides the necessary constituents for maintaining homeostasis of tissue (Fuchs et al., 2004). 
In cancer cells such control is lost and that restoring the niche may result in maintaining the 
homeostasis of growth and normal differentiation. 
Hence to understand the mechanism Lynne-Marie Postovit et al (2006) developed an in vitro 
3D model to investigate the capacity of hESC-derived factors to epigenetically influence 
metastatic cancer cells. They showed exposure of melanoma cells to a hESC 
microenvironment results in the reexpression of melanocyte-specific markers which are 
indicative of differentiation and a reduction in invasive potential.  
Further (Lynne-Marie Postovit, 2006) they discovered that hESC microenvironments 
suppress the tumorigenic phenotype of human metastatic melanoma and breast carcinoma 
cells and that this effect is is brought about only by hESCs and not other stem cell types. 
Further they found that hESC microenvironment neutralize the aberrant expression of 
Nodal in metastatic melanoma and breast carcinoma cells and reprogram them to a less 
aggressive phenotype (Postovit et al., 2006a; b). They also identified lefty which is sectreted 
by hESC (an inhibitor of Nodal signaling) as an important mediator of these phenomena. 
Hence the microenvironment of hESCs provides a previously unexplored therapeutic entity 
for the regulation of aberrantly expressed embryonic factor(s) in aggressive tumor cells 
(Postovit et al., 2008). 
3. Conclusion 
CSC are rare cells and they are distinct from other bulk tumor cells. They generate the tumor 
and maintain the tumor hetrogenity. If the CSCs are elemiminated/differentiated to 
nonCSCs then cancer can be eradicated. The CSC niche maintains the CSC characteristics 
and increases the CSC potential, hence CSC niche offers a critical window treatment of 
cancer. Hence strategies that target the pathways critical for selfrenewal which are 
maintained through niche should be the focus of therapy. Notch, Wnt and Hedgehog 
pathways are known for maintaining self renewal of normal stem cells (Merchant and 
Matsui, 2010; Pannuti et al., 2010; Takahashi-Yanaga and Kahn, 2010). These pathways offers 
targets in combination of other tumor specific markers for CSC targeting. For eg. Farnie, G 
et al., demonstrated that inhibiting notch signaling using gama secretase inhibitors in DCIS 
derived cells decreases their mamosphere forming efficiency (Farnie et al., 2007). Further 
antibodies against the ECM Protein fibronectin receptor ┙4┚1 integrin prevented the 
interaction of cancer cells with premetastatic niches and reduce the minimal residual disease 
(Kaplan et al., 2005). Moreover antibodies to fibronectin and ┚1 integrin promoted epithelial 
phenotype of invasive breast cancer cells in organotypic three dimentional cultures (Sandal 
et al., 2007). Hence when formulating such therapeutic modalities a combination of 
inhibitors/biomolecules which can efficiently inhibit the cancer stem cells self renewal 
should be considered.  
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